Mechanism of action and function of novel secosteroid 20(OH)D3 in the skin
Mechanism of action and function of novel secosteroid 20(OH)D3 in the skin
批准号:
9914825
负责人:
ANDRZEJ T SLOMINSKI
金额:
$32.67万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-05-01 至 2023-04-30
关键词:
7-dehydrocholesterolAcidsAdrenal GlandsAffectAgonistAnti-Inflammatory AgentsApoptosisAttenuatedBindingBioinformaticsBiologicalBlood CirculationCYP11A1 geneCYP27B1 geneCalcitriolCalciumCell Differentiation processCellsChIP-seqCholecalciferolClinicalComplementComplexComputer ModelsDNA RepairDefectDevelopmentDoseEndocrineEpidermisFibroblastsGene ChipsGene SilencingGenesGenetic Complementation TestGenetic TranscriptionGenotypeGoalsHeterozygoteHomeostasisHormonalHumanHydroxylationIn VitroLaboratoriesLigand Binding DomainLigandsMeasuresMediatingMetabolicMetabolismModelingMusNuclearOrphanOutcomeOxidesPathologyPathway interactionsPharmacologyPhenotypePositioning AttributeProcessRadiation ProtectionRecombinantsRegulationRoleSecosteroidsSerumSideSkinSuggestionTechnologyTestingTretinoinUVB inducedUltraviolet B RadiationVitamin DVitamin D3 Receptoranalogbasedata modelingimmunoregulationkeratinocytekeratinocyte differentiationmelanocytemolecular modelingnovelorphan nuclear receptor ROR-gammapreventprogramsreceptorrepairedresponsesingle moleculeskin barrierstressortranscriptome sequencingultraviolet
中文摘要
紫外线B既损害皮肤,也是7-脱氢胆固醇光化学转化所必需的
英文摘要
Ultraviolet B both damages the skin and is required for photochemical transformation of 7-dehydrocholesterol
to vitamin D3 (D3). Its sequential hydroxylation at C25 and C1 generates biologically active 1,25(OH)2D3 that
displays a variety of pleiotropic activities. It was believed that all of these effects are mediated by single
molecule, 1,25(OH)2D3, and single receptor, VDR. Discovery of an alternative pathway in which CYP11A1
oxidizes the side chain of D3 producing 20(OH)D3 with its further metabolism to other downstream-derivatives,
(OH)nD3, challenged this dogma. 20(OH)D3 is detectable in the human epidermis at concentration higher than
25(OH)D3, and in human serum at ~3nM. 20(OH)D3 shows biological activities suggestive that it can act as an
endogenous regulator of epidermal barrier, while its presence in circulation suggests hormonal functions.
20(OH)D3 is noncalcemic at pharmacological doses (30-60µg/kg). Initial data and computer modeling indicate
that it can act as biased agonist on VDR and reverse agonist on RORα and RORγ. Hypothesis: 20(OH)D3
and/or its metabolites acting directly on VDR and/or RORα and RORγ stimulate keratinocyte differentiation
program and photoprotective and repair mechanisms that protect epidermis against UVB-induced pathology.
These effects would not require its hydroxylation in position C1α, in contrast to 1,25(OH)2D3. The hypothesis
will be tested as follows: Aim 1. To test the relative role of VDR, RORα, or RORγ in 20(OH)D3 mediated
regulation of the proliferation and differentiation programs in epidermal keratinocytes. Subaim 1: Through in
vitro binding to the ligand-binding domain of recombinant VDR and RORs we will define relative interactions of
20(OH)D3 and its downstream metabolites with the receptors in comparison to their native ligands. Then we
will apply complex cell-based models to measure ligands modulated transcriptional activities. These will be
supplemented by molecular modeling analyses. Subaim 2: The relative roles of VDR and RORs in regulation
of keratinocytes proliferation and differentiation will be tested using gene silencing technology. This will be
complemented by tests on keratinocytes isolated from VDR-/-, RORα-/- or RORγ-/- mice. Subaim 3: RNA-Seq
for gene expression and ChIP-Seq for receptor enrichment on target genes followed by bioinformatics
analyses to identify alternative targets. Aim 2. To define protective role of 20(OH)D3 against UVB radiation in
the human epidermis. Subaim 1: Testing the role of 20(OH)D3 as a survival factor. Subaim 2: Testing whether
20(OH)D3 attenuates UVB induced apoptosis. Subaim 3: Testing whether 20(OH)D3 can act as an
antigenotoxic/antimutagenic agent. Subaim 4: Testing the role of RORα or RORγ in skin responses to the
UVB using mice with genotype -/-,-/+ and +/+ for these receptors and comparing with mice with defective or intact
VDR. Aim 3. To evaluate whether the phenotypic effects of 20(OH)D3 and its metabolites require 1α
hydroxylation as described for 1,25(OH)2D3. We will use cells with silenced CYP27B1 gene. This will be
complemented by pharmacological inhibition of the CYP27B1 activity in keratinocytes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CYP11A1-derived secosteroids as therapeutic agents in UVB induced skin cancer
-
批准号:10436919
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:ANDRZEJ T SLOMINSKI
-
依托单位:
CYP11A1-derived secosteroids as therapeutic agents in UVB induced skin cancer
-
批准号:10630816
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:ANDRZEJ T SLOMINSKI
-
依托单位:
CYP11A1-derived secosteroids as therapeutic agents in UVB induced skin cancer
-
批准号:10265344
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:ANDRZEJ T SLOMINSKI
-
依托单位:
Mechanism of action and function of novel secosteroid 20(OH)D3 in the skin
-
批准号:10401256
-
项目类别:
-
资助金额:$32.34万
-
财政年份:2018
-
负责人:ANDRZEJ T SLOMINSKI
-
依托单位:
Significance of metabolic activation of lumisterol in the skin
-
批准号:10238125
-
项目类别:
-
资助金额:$31.86万
-
财政年份:2017
-
负责人:ANDRZEJ T SLOMINSKI
-
依托单位:
Significance of metabolic activation of lumisterol in the skin
-
批准号:9756150
-
项目类别:
-
资助金额:$32.85万
-
财政年份:2017
-
负责人:ANDRZEJ T SLOMINSKI
-
依托单位:
Mechanism of action of 20-hydroxyvitamin D3 in dermal fibroblasts
-
批准号:9101104
-
项目类别:
-
资助金额:$18.72万
-
财政年份:2015
-
负责人:ANDRZEJ T SLOMINSKI
-
依托单位:
Role of Exogenous Melatonin in Skin Biology
-
批准号:8874110
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2015
-
负责人:ANDRZEJ T SLOMINSKI
-
依托单位:
Mechanism of action of 20-hydroxyvitamin D3 in dermal fibroblasts
-
批准号:8930444
-
项目类别:
-
资助金额:$16.17万
-
财政年份:2015
-
负责人:ANDRZEJ T SLOMINSKI
-
依托单位:
Role of exogenous melatonin in skin biology
-
批准号:8675728
-
项目类别:
-
资助金额:$14.29万
-
财政年份:2011
-
负责人:ANDRZEJ T SLOMINSKI
-
依托单位:
Role of exogenous melatonin in skin biology
-
批准号:8476985
-
项目类别:
-
资助金额:$31.64万
-
财政年份:2011
-
负责人:ANDRZEJ T SLOMINSKI
-
依托单位:
Role of exogenous melatonin in skin biology
-
批准号:8307486
-
项目类别:
-
资助金额:$33.04万
-
财政年份:2011
-
负责人:ANDRZEJ T SLOMINSKI
-
依托单位:
Role of exogenous melatonin in skin biology
-
批准号:8187799
-
项目类别:
-
资助金额:$33.3万
-
财政年份:2011
-
负责人:ANDRZEJ T SLOMINSKI
-
依托单位:
The pigmentary system: securing a place in the sun
-
批准号:7748495
-
项目类别:
-
资助金额:$2.2万
-
财政年份:2009
-
负责人:ANDRZEJ T SLOMINSKI
-
依托单位:
Novel Biosynthetic Pathway for Secosteroids and the Skin
-
批准号:7903172
-
项目类别:
-
资助金额:$37.68万
-
财政年份:2006
-
负责人:ANDRZEJ T SLOMINSKI
-
依托单位:
Novel biosynthetic pathway for secosteroids and the skin
-
批准号:7143636
-
项目类别:
-
资助金额:$41.3万
-
财政年份:2006
-
负责人:ANDRZEJ T SLOMINSKI
-
依托单位:
Novel biosynthetic pathway for secosteroids and the skin
-
批准号:7274878
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2006
-
负责人:ANDRZEJ T SLOMINSKI
-
依托单位:
Novel Biosynthetic Pathway for Secosteroids and the Skin
-
批准号:7470587
-
项目类别:
-
资助金额:$37.85万
-
财政年份:2006
-
负责人:ANDRZEJ T SLOMINSKI
-
依托单位:
Novel Biosynthetic Pathway for Secosteroids and the Skin
-
批准号:7655315
-
项目类别:
-
资助金额:$37.02万
-
财政年份:2006
-
负责人:ANDRZEJ T SLOMINSKI
-
依托单位:
Role of CRH in skin physiology and pathology
-
批准号:6801020
-
项目类别:
-
资助金额:$23.95万
-
财政年份:2002
-
负责人:ANDRZEJ T SLOMINSKI
-
依托单位:
国内基金
海外基金
登录
查看更多内容
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
-
批准号:22007039
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王黎明
-
依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:朱义广
-
依托单位:
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
-
批准号:21372217
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:袁伟成
-
依托单位:
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
-
批准号:21172061
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2011
-
负责人:许新华
-
依托单位:
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
-
批准号:21176225
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:童少平
-
依托单位:
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
-
批准号:81072511
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:严江伟
-
依托单位:
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
-
批准号:30660215
-
项目类别:地区科学基金项目
-
资助金额:21.0万元
-
批准年份:2006
-
负责人:王世范
-
依托单位: